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In this work we developed a new synthetic strategy towards the solomonamides. a novel class of
cyclopeptides of marine origin. The described synthetic approach utilized an olefin metathesis reaction
to form the [15]-membered ring contained in these natural products. During the synthetic process, a
diverse set of analogues was generated and we evaluated their potential antitumor activity in vitro. For
this purpose we performed in vitro proliferation assays, determining the IC50 values of the compounds
in a panel of tumor cell lines. In addition, we evaluated the possible antiangiogenic effects of these
solomonamide analogues by using in vitro endothelial cell differentiation assays. Our results showed
that the potential antitumor and antiangiogenic activity of the studied analogues depended on their
chemical structure, suggesting that the presence of specific functional groups could be responsible of
their biological activity. Further studies are needed to understand the basis of the observed activities in
endothelial and tumor cells.
